In early phase trials innovative designs offer potential for improvements in efficiency and decision-making. Determining the ...

The Janus Henderson Global Sustainable Equity Managed Account Portfolio returned -5.71% (gross) for Q4 2024. Click here to read the full commentary.

Find Biotech Icons stock video, 4K footage, and other HD footage from iStock. Get higher quality Biotech Icons content, for less—All of our 4K video clips are the same price as HD. Video Back Videos ...

Fortunately, we are making some progress as organizations such as the Partnership for Advancing Clinical Trials (PACT) ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced ...

Outperformance during the fourth quarter primarily resulted from stock selection and an overweight in industrials. Read more ...

ICON Public Limited Company (NASDAQ:ICLR) provides outsourced clinical research and commercialization services, supporting all stages of clinical development for pharmaceutical, biotechnology ...

Twenty-five years ago, the bestseller “The Tipping Point” turned Malcolm Gladwell into a household name. Describing “the critical mass, the threshold, the boiling point,” Gladwell illustrates ...

True crime shows based on real events provide insights into notorious cases, with some of the best including series like Narcos and When They See Us.

EZZ has served up a strong H2 FY25 result, with several financial and operational achievements throughout the quarter. ... Read More The post ASX Quarterly Health Wrap: EZZ hits an ace, ReNerve’s ...

Moleculin Biotech (MBRX) has received FDA feedback and guidance on its IND amendment that has allowed a reduction in the size of its Phase 3 ...

NKGen Biotech (NKGN) announced that the U.S. Food and Drug Administration, FDA, has granted Fast Track designation, FTD, for the investigation ...